ClinicalTrials.gg
CompletedNCT07300839Updated Oct 16, 2026

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

A Phase 3 interventional study of BNT162b2 Vaccine and Placebo in COVID-19 and SARS-COV-2 Infection, sponsored by BioNTech SE. Completed at 196 sites in United States. Open to participants aged 50 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by BioNTech SE · Phase 3, Interventional, and Prevention

Updated Oct 16, 2026Now CompletedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
5,240
Allocation
Randomized
Ages
50 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 54 studies testing BNT162 Vaccine in COVID-19 — 4 open to participants now, 6 under way, 1 of them phase 3. BNT162 Vaccine · COVID-19.

Enrollment
4th of 54
5,240 · median 575
Started
2025
with 3 others
Phase 3
18 of 54
1 open now
Registered
52nd of 54
by date
Lead sponsor
20 of 54
BioNTech SE

Among the 54 studies testing BNT162 Vaccine in COVID-19, this one is the 4th largest by enrollment, is one of 4 that started in 2025, is one of 18 in phase 3, and was the 52nd registered.

COVID-19

7,994 studies on the registry are indexed under COVID-19; 468 are open to participants now.

Browse COVID-19 studies →

Open to participants now

4 of the 54 studies testing BNT162 Vaccine in COVID-19 are open now, in 6 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

About BNT162 Vaccine

No approval found in the FDA or EMA files read. How studies give it is on its page →

Who these studies take

Of the 356 COVID-19 studies recruiting now, 206 (58%) set no upper age limit and 83 (23%) stop at 75 or younger; 91 take children under 18; 135 take healthy volunteers.

This study: 50 Years to 64 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies testing BNT162 Vaccine in COVID-19, or all of them as a file.
02

Study summary

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).

Read the detailed description

The study is designed to evaluate if the COVID-19 vaccine reduces COVID-19 disease as compared to placebo given to healthy adults 50 to 64 years of age. Approximately 25,500 participants will be randomly chosen to get either one dose of COVID-19 vaccine or of a placebo.

03

Conditions studied

  • COVID-19
  • SARS-COV-2 Infection

Browse trials for

04

Who can participate

Ages eligible
50 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Key Inclusion Criteria

  • People who are between 50 and 64 years old at their first appointment.
  • People who are healthy and, based on their medical history and a doctor's judgment, are considered suitable to join the study.

Key Exclusion Criteria

  • People who had COVID-19 in the past 3 months (90 days) before their first visit.
  • People who got a COVID-19 vaccine, either as part of a research study or an approved vaccine, in the last 3 months-or plans to get one during the study.
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
5,240 participants (actual)

Study arms

  • Experimental
    BNT162b2 Vaccine

    Biological: BNT162b2 Vaccine

  • Placebo comparator
    Placebo

    Biological: Placebo

Interventions

06

What researchers measure

Primary outcomes

  1. Percentage of participants reporting local reactions or systemic events

    Time frame: From Day 1 up to 7 days after Vaccination

  2. Percentage of participants reporting adverse events

    Time frame: From Day 1 through 4 weeks after vaccination

  3. Percentage of participants reporting serious adverse events

    Time frame: From Day 1 through 6 months after vaccination

  4. First episode of confirmed COVID-19 cases

    Time frame: From 0 days after vaccination through end of COVID-19 surveillance at least 6 months post-vaccination

Secondary outcomes

  1. First episode of confirmed COVID-19 cases

    Time frame: From 7 days after vaccination through end of COVID-19 surveillance at least 6 months post-vaccination

  2. Geometric Mean Ratio (GMR)

    Time frame: From before vaccination to 1 month after vaccination

07

Study locations

196 sites
  • Pinnacle Research Group, LLC
    Anniston, Alabama 36207, United States
  • North Alabama Research Center
    Athens, Alabama 35611, United States
  • Simon Williamson Clinic / Synexus Clinical Research US, Inc.
    Birmingham, Alabama 35211, United States
  • Accel Research Sites - Birmingham Clinical Research Unit
    Birmingham, Alabama 35216, United States
  • Cullman Clinical Trials
    Cullman, Alabama 35055, United States
  • AMR Clinical
    Daphne, Alabama 36526, United States
  • Medical Affiliated Research Center
    Huntsville, Alabama 35801, United States
  • AMR Clinical
    Mobile, Alabama 36608, United States
  • Chandler Clinical Trials
    Chandler, Arizona 85224, United States
  • Scottsdale Clinical Trials
    Scottsdale, Arizona 85260, United States
  • Epic Medical Research-Sun City
    Sun City, Arizona 85351, United States
  • Noble Clinical Research
    Tucson, Arizona 85704, United States
  • Synexus Clinical Research US, Inc./Orange Grove Family Practice
    Tucson, Arizona 85741, United States
  • Woodland International Research Group, LLC
    Little Rock, Arkansas 72211, United States
  • Anaheim Clinical Trials, LLC
    Anaheim, California 92801, United States
  • Velocity Clinical Research, Chula Vista
    Chula Vista, California 91911, United States
  • West Coast Research
    Dublin, California 94568, United States
  • Triallogix Medical Corporation
    Fullerton, California 92835, United States
  • Upper Echelon Medical
    Fullerton, California 92835, United States
  • Marvel Clinical Research
    Huntington Beach, California 92647, United States
  • Eximia Research-CA, LLC
    La Mesa, California 91942, United States
  • Velocity Clinical Research, Los Angeles
    Los Angeles, California 90057, United States
  • Leading Edge Research
    Los Angeles, California 91316, United States
  • ImmuniMet
    Modesto, California 95350, United States
  • Carbon Health - North Hollywood - NoHo West
    North Hollywood, California 91606, United States
  • Empire Clinical Research
    Pomona, California 91767, United States
  • Peninsula Research Associates
    Rolling Hills Estates, California 90274, United States
  • Northern California Research - Sacramento
    Sacramento, California 95821, United States
  • Velocity Clinical Research, San Bernardino
    San Bernardino, California 92408, United States
  • Artemis Institute for Clinical Research
    San Diego, California 92123, United States
  • Med Partners, Inc. dba Premiere Medical Center of Burbank, Inc.
    Toluca Lake, California 91602, United States
  • Diablo Clinical Research, Inc.
    Walnut Creek, California 94598, United States
  • Legacy Clinical Trials
    Colorado Springs, Colorado 80909, United States
  • Tekton Research, LLC.
    Fort Collins, Colorado 80525, United States
  • Tekton Research, LLC.
    Longmont, Colorado 80501, United States
  • Paradigm Clinical Research Centers, LLC
    Wheat Ridge, Colorado 80033, United States
  • Clinical Research Consulting
    Milford, Connecticut 06460, United States
  • Stamford Therapeutics Consortium
    Stamford, Connecticut 06905, United States
  • Washington Health Institute
    Washington D.C., District of Columbia 20017, United States
  • International Clinical Research - FL, LLC
    Altamonte Springs, Florida 32701, United States
  • Tampa Bay Medical Research
    Clearwater, Florida 33761, United States
  • Hillcrest Medical Research
    DeLand, Florida 32720, United States
  • Universal Axon Clinical Research, LLC
    Doral, Florida 33166, United States
  • Suncoast Research Associates
    Doral, Florida 33172, United States
  • AMR Clinical
    Fort Myers, Florida 33912, United States
  • Robert B. Pritt, DO
    Fort Myers, Florida 33912, United States
  • Velocity Clinical Research, Hallandale Beach
    Hallandale, Florida 33009, United States
  • Indago Research & Health Center, Inc
    Hialeah, Florida 33012, United States
  • Las Mercedes Medical Research
    Hialeah, Florida 33012, United States
  • Research Centers of America
    Hollywood, Florida 33024, United States
  • Jacksonville Center for Clinical Research
    Jacksonville, Florida 32216, United States
  • Health Awareness, LLC
    Jupiter, Florida 33458, United States
  • M3 Wake Research - Lake City
    Lake City, Florida 32055, United States
  • SRA Trials North
    Lauderdale Lakes, Florida 33313, United States
  • Accel Research Sites - Maitland Clinical Research Unit
    Maitland, Florida 32751, United States
  • South Florida Research Organization
    Medley, Florida 33166, United States
  • Optimal Research
    Melbourne, Florida 32934, United States
  • Flourish Research - Miami, LLC
    Miami, Florida 33135, United States
  • Florida Pharmaceutical Research & Associates, Inc.
    Miami, Florida 33143, United States
  • Nuren Medical and Research Center
    Miami, Florida 33144, United States
  • Advanced Clinical Research - Miami - Southwest 92nd Street
    Miami, Florida 33156, United States
  • New Horizon Research Center
    Miami, Florida 33165, United States
  • Entrust Clinical Research
    Miami, Florida 33176, United States
  • IMIC Medical Research
    Miami, Florida 33176, United States
  • Miami Dade Medical Research Institute, LLC
    Miami, Florida 33176, United States
  • Pioneer Clinical Studies
    Miami, Florida 33176, United States
  • 3Sync Research
    Miami Lakes, Florida 33014, United States
  • Palm Springs Community Health Center
    Miami Lakes, Florida 33014, United States
  • Angels Clinical Research Institute
    Miami Lakes, Florida 33016, United States
  • Clinical Neuroscience Solutions, Inc.
    Orlando, Florida 32801, United States
  • Headlands Research Orlando
    Orlando, Florida 32806, United States
  • 3Sync Research
    Palm Springs, Florida 33461, United States
  • Innovation Medical Research Center
    Palmetto Bay, Florida 33157, United States
  • Tropical Clinical Trials
    Palmetto Bay, Florida 33176, United States
  • Suncoast Research Associates
    Pembroke Pines, Florida 33024, United States
  • DBC Research USA
    Pembroke Pines, Florida 33029, United States
  • Progressive Medical Research
    Port Orange, Florida 32127, United States
  • GCP Research, Global Clinical professionals
    St. Petersburg, Florida 33705, United States
  • Precision Clinical Research
    Sunrise, Florida 33351, United States
  • Angels Clinical Research Institute
    Tampa, Florida 33614, United States
  • Santos Research Center
    Tampa, Florida 33615, United States
  • Synexus Clinical Research US, Inc.
    The Villages, Florida 32162, United States
  • Palm Beach Research Center
    West Palm Beach, Florida 33409, United States
  • M3 Wake Research - Atlanta
    Atlanta, Georgia 30328, United States
  • DelRicht Research
    Atlanta, Georgia 30329, United States
  • AGILE Clinical Research Trials, LLC
    Sandy Springs, Georgia 30328, United States
  • Javara - Privia Medical Group Georgia - Savannah
    Savannah, Georgia 31406, United States
  • Clinical Research Atlanta
    Stockbridge, Georgia 30281, United States
  • Rophe Adult and Pediatric Medicine/SKYCRNG
    Union City, Georgia 30291, United States
  • East-West Medical Research Institute
    Honolulu, Hawaii 96814, United States
  • Chicago Clinical Research Institute Inc.
    Chicago, Illinois 60607, United States
  • DM Clinical Research - Chicago
    Melrose Park, Illinois 60160, United States
  • Koch Family Medicine
    Morton, Illinois 61550, United States
  • Accellacare - DuPage
    Oak Lawn, Illinois 60453, United States
  • The South Bend Clinic /Avacare
    South Bend, Indiana 46617, United States
  • University of Iowa
    Iowa City, Iowa 52242, United States
  • Velocity Clinical Research, Sioux City
    Sioux City, Iowa 51106, United States
  • AMR Clinical
    El Dorado, Kansas 67042, United States
  • Johnson County Clinical Trials
    Lenexa, Kansas 66219, United States
  • AMR Clinical
    Newton, Kansas 67114, United States

Showing the first 100 of 196 sites. Choose a country and city above to see the rest.

08

References and documents

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Sep 2026, 9 months.

Of 168 industry-sponsored phase 3 interventional studies under COVID-19, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 16. This study's 9 months is above that.

Counting every sponsor, half of 453 studies reached it within 9 months; a quarter within 4 and three quarters within 17.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: primary completion Jul 2026 → Sep 2026 and completion Jul 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2025
First posted
Dec 24, 2025
StartActual
Dec 10, 2025
Primary completionActual
Sep 22, 2026was Jul 2026
CompletionActual
Sep 22, 2026was Jul 2026
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 16, 2026
Primary completion
Jul 31, 2026→Sep 22, 2026 (actual)
Oct 16, 2026
Study completion
Jul 31, 2026→Sep 22, 2026 (actual)
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Active, not recruiting→Completed
    Primary completion Jul 31, 2026→Sep 22, 2026 (now actual)
    Study completion Jul 31, 2026→Sep 22, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07300839
Lead sponsor
BioNTech SE
Collaborators
Pfizer
Responsible party
Sponsor
First posted
Dec 24, 2025
Start date
Dec 10, 2025
Primary completion
Sep 22, 2026
Completion
Sep 22, 2026
Last update
Oct 16, 2026

Study contacts

Pfizer CT.gov Call Center
study director · Pfizer

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: BNT162 Vaccine

Start the discussion